Literature DB >> 22018063

Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006.

Ahmedin Jemal1, Mona Saraiya, Pragna Patel, Sai S Cherala, Jill Barnholtz-Sloan, Julian Kim, Charles L Wiggins, Phyllis A Wingo.   

Abstract

BACKGROUND: Increasing cutaneous melanoma incidence rates in the United States have been attributed to heightened detection of thin (≤ 1-mm) lesions.
OBJECTIVE: We sought to describe melanoma incidence and mortality trends in the 12 cancer registries covered by the Surveillance, Epidemiology, and End Results program and to estimate the contribution of thin lesions to melanoma mortality.
METHODS: We used joinpoint analysis of Surveillance, Epidemiology, and End Results incidence and mortality data from 1992 to 2006.
RESULTS: During 1992 through 2006, melanoma incidence rates among non-Hispanic whites increased for all ages and tumor thicknesses. Death rates increased for older (>65 years) but not younger persons. Between 1998 to 1999 and 2004 to 2005, melanoma death rates associated with thin lesions increased and accounted for about 30% of the total melanoma deaths. LIMITATIONS: Availability of long-term incidence data for 14% of the US population was a limitation.
CONCLUSIONS: The continued increases in melanoma death rates for older persons and for thin lesions suggest that the increases may partly reflect increased ultraviolet radiation exposure. The substantial contribution of thin lesions to melanoma mortality underscores the importance of standard wide excision techniques and the need for molecular characterization of the lesions for aggressive forms.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018063     DOI: 10.1016/j.jaad.2011.04.032

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  127 in total

1.  Underreporting of Melanoma in Arizona and Strategies for Increasing Reporting: A Public Health Partnership Approach.

Authors:  Robin B Harris; Stephanie M Koch; Chris Newton; Nancy G Silvis; Clara Curiel-Lewandroski; Joseph Giancola; Paul Sagerman; Steven Alder; Georgia Yee; Timothy J Flood
Journal:  Public Health Rep       Date:  2015 Nov-Dec       Impact factor: 2.792

2.  Trends in the frequency of original research in acne vulgaris, rosacea, dermatitis, psoriasis, skin cancer, and skin infections, 1970-2010.

Authors:  Young M Choi; Jashin J Wu
Journal:  Perm J       Date:  2015

3.  Melanoma metastasis to the gastric mucosa preceded by guillain-barré as a paraneoplastic syndrome.

Authors:  Rodrigo Kraft Rovere; Maria Eduarda Pires de Souza; Sara Fernanda Hilgert; Yasmine Rodrigues Chamse Ddine; Adma Silva de Lima
Journal:  Gastrointest Cancer Res       Date:  2013-09

4.  Role of TRPM in melanocytes and melanoma.

Authors:  Huazhang Guo; John Andrew Carlson; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

5.  Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia.

Authors:  Evisabel A Craig; Jonathan D Weber; Vladimir S Spiegelman
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

6.  The association between demographic and behavioral characteristics and sunburn among U.S. adults - National Health Interview Survey, 2010.

Authors:  Dawn M Holman; Zahava Berkowitz; Gery P Guy; Anne M Hartman; Frank M Perna
Journal:  Prev Med       Date:  2014-02-28       Impact factor: 4.018

7.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Authors:  Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

Review 8.  Update on the targeted therapy of melanoma.

Authors:  Douglas B Johnson; Jeffrey A Sosman
Journal:  Curr Treat Options Oncol       Date:  2013-06

9.  Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target.

Authors:  Guo Chen; Nitin Chakravarti; Kimberly Aardalen; Alexander J Lazar; Michael T Tetzlaff; Bradley Wubbenhorst; Sang-Bae Kim; Scott Kopetz; Alicia A Ledoux; Y N Vashisht Gopal; Cristiano Goncalves Pereira; Wanleng Deng; Ju-Seog Lee; Katherine L Nathanson; Kenneth D Aldape; Victor G Prieto; Darrin Stuart; Michael A Davies
Journal:  Clin Cancer Res       Date:  2014-05-06       Impact factor: 12.531

10.  Melanoma burden and recent trends among non-Hispanic whites aged 15-49years, United States.

Authors:  Meg Watson; Alan C Geller; Margaret A Tucker; Gery P Guy; Martin A Weinstock
Journal:  Prev Med       Date:  2016-08-24       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.